Paul A. Jones Sells 10,696 Shares of USANA Health Sciences, Inc. (USNA) Stock

USANA Health Sciences, Inc. (NYSE:USNA) insider Paul A. Jones sold 10,696 shares of the firm’s stock in a transaction that occurred on Thursday, March 8th. The shares were sold at an average price of $81.00, for a total transaction of $866,376.00. Following the transaction, the insider now directly owns 10,696 shares of the company’s stock, valued at approximately $866,376. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

USANA Health Sciences, Inc. (NYSE:USNA) opened at $80.70 on Tuesday. USANA Health Sciences, Inc. has a one year low of $52.55 and a one year high of $81.90. The firm has a market cap of $1,940.00, a P/E ratio of 21.46 and a beta of 0.94.

How to Become a New Pot Stock Millionaire

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, February 6th. The company reported $1.11 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.00 by $0.11. USANA Health Sciences had a net margin of 5.97% and a return on equity of 27.08%. The business had revenue of $273.11 million during the quarter, compared to the consensus estimate of $258.67 million. During the same quarter last year, the firm earned $0.87 earnings per share. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. equities analysts predict that USANA Health Sciences, Inc. will post 4.25 earnings per share for the current fiscal year.

Several hedge funds and other institutional investors have recently made changes to their positions in USNA. US Bancorp DE increased its stake in shares of USANA Health Sciences by 730.1% during the fourth quarter. US Bancorp DE now owns 2,374 shares of the company’s stock valued at $176,000 after purchasing an additional 2,088 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new stake in shares of USANA Health Sciences during the third quarter valued at approximately $189,000. Creative Planning purchased a new stake in shares of USANA Health Sciences during the fourth quarter valued at approximately $219,000. Hikari Power Ltd purchased a new stake in shares of USANA Health Sciences during the fourth quarter valued at approximately $255,000. Finally, Stone Ridge Asset Management LLC purchased a new stake in shares of USANA Health Sciences during the fourth quarter valued at approximately $265,000. 48.25% of the stock is owned by institutional investors and hedge funds.

USNA has been the subject of a number of analyst reports. Sidoti downgraded shares of USANA Health Sciences from a “buy” rating to a “neutral” rating in a research note on Wednesday, January 24th. TheStreet downgraded shares of USANA Health Sciences from a “b+” rating to a “c+” rating in a research note on Tuesday, February 6th. Finally, Pivotal Research raised their target price on shares of USANA Health Sciences from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, February 7th.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Markets Daily and is the property of of Markets Daily. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.themarketsdaily.com/2018/03/13/paul-a-jones-sells-10696-shares-of-usana-health-sciences-inc-usna-stock.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply